Business Wire

Xlear Files Amended Answer to the Government’s Lawsuit on COVID-19 Statements; Provides Still More Data In Support of Xlear’s Use as Additional Layer of Protection


Xlear has filed an Amended Answer in response to the U.S. Government’s lawsuit against the company. According to Nathan Jones, Xlear’s CEO, the Amended Answer serves three main purposes: First, it provides the Court with still more data that supports the statements Xlear made that nasal hygiene is an additional layer of protection in fighting COVID-19, that our public health officials are ignoring; Second, it lays out in greater detail how the U.S. Government’s lawsuit is an effort to censor science that doesn’t comport with the Government’s vaccine-myopic, failing strategy to combat the disease; Third, it documents how experts, including Dr. Fauci, are increasingly saying the nose is the critical place to fight the virus.

Xlear’s Amended Answer provides two new studies that support the statements Xlear made about the use of its nasal spray as a potential additional layer of protection against COVID-19:

  • A new in vitro study found that use of a simple saline solution stops SAR-CoV2 viral replication in human lung tissue. Rafael R. G. Machado, Talita Glaser, Danielle B. Araujo, Lyvia Lintzmaier Petiz, Danielle B. L. Oliveira, Giuliana S. Durigon, Alessandra L. Leal, João Renato R. Pinho, Luis C. S. Ferreira, Henning Ulrich, Edison L. Durigon, and Cristiane Rodrigues Guzzo, ACS Pharmacology & Translational Science 2021 4 (5), 1514-1527, available at Nate Jones, CEO of Xlear noted, “The Government agrees, Xlear is a saline nasal solution. This in vitro study documents that saline nasal hygiene helps stop COVID-19 from replicating in nasal tissue—which we know is where the virus typically grows and infects people.”
  • New in silico research determined that compounds of grapefruit seed extract (GSE) were effective inhibitors of the SARS-CoV-2 virus. Belmina Saric, et al., In silico analysis of selected components of grapefruit seed extract SARS-CoV-2 main protease, EuroBiotech J., 5 (special issue 1); 2021, 5. DOI: Most importantly, these experts concluded natural GSE—which is a component of Xlear—was more effective than synthetic versions of the compound.

Jones continued: “These aren’t the Random Clinical Trials the Government is so focused on—but you can’t deny the mounting wall of evidence that nasal hygiene should be used as an additional layer of protection against COVID-19. Moreover, the Government recently announced that it won’t require Random Clinical Trials for the new variant vaccines—that requirement seems to only apply when it is convenient for the Government.”

Jones also noted that the SARS-CoV-2 variants are all strains of coronavirus, and experts have long recommended nasal hygiene to combat coronaviruses. “As a rule, prevention methods and symptom-reduction modalities (e.g., over the counter drugs, handwashing) are not variant specific; they are used against colds and flus on the whole, many caused by coronaviruses. One countermeasure that experts, including the US Government, recommend to fight the common cold, including coronavirus-infections, is nasal hygiene.” DeGeorge KC, Ring DJ, Dalrymple SN. Treatment of the Common Cold. Am Fam Physician. 2019 Sep 1;100(5):281-289. PMID: 31478634, reprinted by NIH as authority at (“Treatments with proven effectiveness for cold symptoms [coronavirus infections] in adults include over-the-counter analgesics, zinc, nasal decongestants . . . The only established safe and effective treatments for children are . . . nasal saline irrigation . . .”). “It’s commonsense, something our Government’s response to COVID seems to be lacking,” Jones added.

As part of its efforts to silence Xlear, the Government asked the Utah Federal Court to preclude Xlear from filing the Amended Answer. The Federal Court ruled in Xlear’s favor. The Court’s ruling specifically noted: “The court shares some concern here, as expressed by Defendants, that the underlying purpose [in the Government’s motion to prevent Xlear’s Amended Answer] is to prevent discovery into disputed facts that may lend support to Defendants’ proposed amendments.” “In other words, the Government is doing everything they can stonewall us from shining a light on their failed COVID-19 response,” Jones added.

“A new more infectious and more dangerous variant is sweeping the nation. Infections are up. Hospitalizations are up. Deaths are up. At the same time, fewer and fewer people are willing to get vaccinated for the third, fourth, who knows how many times,” Jones noted. “It’s obvious we need a new, broader—'vaccine-plus’—approach. But rather than educate people, the Government is suing us in retaliation for talking about the science. I’m deeply afraid even telling the Court about these new studies will bring more Government retaliation, however in the face of the Government’s failure what choice is there. When science gives way to dogma, people suffer,” Jones concluded.

To view this piece of content from, please give your consent at the top of this page.

Contact information

Xlear Media Relations
Nathan Jones

About Business Wire

Business Wire
Business Wire

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Board International Announces Strategic Alliance With Oliver Wight26.9.2022 12:00:00 CEST | Press release

Board International, the Intelligent Planning Platform which delivers solutions that help organizations plan smarter — enabling actionable insights and better outcomes, today announced a strategic alliance with leading management consultants and business transformation specialists Oliver Wight (AP and EAME). The new partnership will use Board’s Intelligent Planning capabilities in conjunction with Oliver Wight’s Integrated Business Planning (IBP) model, industry-leading business transformation methodology and expertise, to realize customers’ Business Planning vision in a unified, integrated solution. The combined offer from Board and Oliver Wight will empower customers to accelerate change, mitigate risk, and realize rewards faster, whilst ensuring self-sufficient delivery of successful integrated business planning initiatives by aligning people, process, and technology together in one joint offer. “We are excited about the combined impact of this new alliance with Oliver Wight for our

PCTEL Announces its New MultiFin Antenna for Intelligent Transportation Systems Communications26.9.2022 12:00:00 CEST | Press release

PCTEL, Inc. (Nasdaq: PCTI), a leading global provider of wireless technology solutions, today announced its new MultiFin configurable antenna for public safety, fleet management and intelligent transportation applications. The MultiFin 7-in-1 antenna offers a robust RF performance in a discreet, rugged low-profile shark fin design. Configurable and optimized for multiband applications, this antenna allows for easy integration with customers’ existing antenna systems. Mattias Hellgren, PCTEL’s Senior RF Engineer & Product Manager, commented, “Flexibility and adaptability are important to our customers. The new MultiFin antenna allows the simultaneous operation of customers’ existing radio networks (TETRA, TETRAPOL, DMR, P25), along with new LTE 4G and 5G networks and WiFi 6E applications. It is designed to support multi system solutions for diverse applications in public safety, mass transit, telematics, infotainment systems and fleet management. We are excited to offer our new antenna

ALL4PACK Emballage Paris – 21 to 24 November 2022: the leading international trade fair for all sustainable packaging and intralogistics solutions26.9.2022 10:00:00 CEST | Press release

The benchmark event at the end of the year (21-24 November 2022 - Paris Nord Villepinte, France), ALL4PACK Emballage Paris is the leading international trade fair for all sustainable packaging and intralogistics solutions, covering the whole production line, including machines. ALL4PACK is a source of inspiration, offering support to all industry stakeholders who are faced with ongoing and future challenges. Against this backdrop, the fair stands out by decoding market developments and regulations, and by showcasing the latest innovations. A new approach approved by exhibitors ALL4PACK Emballage Paris offers a complete range of packaging and machinery solutions for all types of industry. To date, 1,300 exhibitors are expected, of which about 50% are international exhibiters. In fact, 96% of the exhibition space has already been booked. Various leading companies such as ATLANTA STRETCH, AUER, BFR SYSTEMS, DOMINO, FILPACK, FRANPACK, FROMM, G.MONDINI, GETRA, GOGLIO, ISHIDA, KRONES, MARCHE

Adams Street Hires James Charalambides and Launches European Private Credit Strategy26.9.2022 10:00:00 CEST | Press release

Adams Street Partners, LLC, a private markets investment firm with $50 billion in assets under management, announced the launch of its Private Credit platform in Europe with the appointment of James Charalambides as Partner & Head of the European Private Credit team. Mr. Charalambides will be responsible for leading and managing the firm’s private credit-related efforts in Europe and supporting all aspects of the decision-making process – including sourcing, structuring, reviewing, and negotiating deal opportunities in this space. Mr. Charalambides will report to Bill Sacher, Partner & Head of Private Credit at Adams Street. This press release features multimedia. View the full release here: Adams Street Partners has announced the launch of its Private Credit platform in Europe with the appointment of James Charalambides as Partner & Head of the European Private Credit team. (Photo: Business Wire) Since launching its inaugural p

Guillaume Jesel Promoted to President, Global Brands, TOM FORD BEAUTY, BALMAIN BEAUTY and Luxury Business Development26.9.2022 09:00:00 CEST | Press release

Today, The Estée Lauder Companies (NYSE: EL) (“ELC”) announced that Guillaume Jesel has been promoted to President, Global Brands, TOM FORD BEAUTY, BALMAIN BEAUTY and Luxury Business Development, effective immediately. Guillaume will report to Jane Hertzmark Hudis, Executive Group President and also to Tracey T. Travis, Executive Vice President and Chief Financial Officer in her role of overseeing the company’s mergers and acquisitions strategy, for Guillaume’s Luxury Business Development responsibilities. This press release features multimedia. View the full release here: Guillaume Jesel has been promoted to President, Global Brands, TOM FORD BEAUTY, BALMAIN BEAUTY and Luxury Business Development (Photo: Business Wire) In this new position, Guillaume will continue to oversee TOM FORD BEAUTY and also be responsible for the overall strategic direction, global development, management and growth of BALMAIN BEAUTY. Guillaume will wo

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom